BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  H3 Biomedicine Announces Data From Lead Development Program Of H3B-8800 In Pre-Clinical Models Of Hematologic Cancers

  December 6, 2016

   · 

  3 min read
• Biotech Beach

  Axonics Modulation Tech Announces First Fecal Incontinence Patients Implanted With Its Miniaturized Rechargeable Sacral Neuromodulation System

  December 6, 2016

   · 

  2 min read
• Drug Development

  Spectrum Pharma Highlights Survival Advantage In A Case Match Control Analysis Of The PROPEL Study With FOLOTYN (Pralatrexate Injection) At The 58th Annual Meeting Of American Society of Hematology

  December 6, 2016

   · 

  7 min read
• Drug Development

  Alnylam Presents Updated Results From Phase 1/2 Study Of ALN-CC5 In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

  December 6, 2016

   · 

  12 min read
• BioMidwest

  NxGen MDX Announces The Move Of Their Non-Invasive Prenatal Test In-House

  December 6, 2016

   · 

  1 min read
• Business

  WCCT Global Appoints Bill Taaffe As New Chief Executive Officer

  December 6, 2016

   · 

  2 min read
• Drug Development

  Agios Announces New Clinical Data From Dose-Escalation Portion Of Phase I Trial Of Single Agent AG-120 Showing Durable Molecular Responses In Patients With Advanced Hematologic Malignancies

  December 6, 2016

   · 

  11 min read
• Pharm Country

  Egalet Announces Issuance Of New Patent For Egalet-002 And Guardian Technology

  December 6, 2016

   · 

  5 min read
• Drug Development

  Novartis AG Announces Zykadia First-Line Study Results Showing 16.6 Month Progression-Free Survival In Patients With ALK+ Advanced NSCLC

  December 6, 2016

   · 

  14 min read
• Teewinot Life Sciences’ Irish Subsidiary Full Spectrum Laboratories, Ltd. Secures A New U.S. Patent Covering An Apparatus For Biosynthetic Production Of Authentic THCA, CBDA And CBCA Cannabinoids

  December 6, 2016

   · 

  2 min read